Phibro Animal Health Corporation
PAHC
$47.92
-$1.67-3.37%
NASDAQ
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Revenue | 1.46B | 1.40B | 1.30B | 1.19B | 1.11B |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 1.46B | 1.40B | 1.30B | 1.19B | 1.11B |
| Cost of Revenue | 991.31M | 956.65M | 890.59M | 806.46M | 752.12M |
| Gross Profit | 473.02M | 443.03M | 405.62M | 384.23M | 353.96M |
| SG&A Expenses | 289.08M | 277.67M | 267.64M | 260.05M | 249.03M |
| Depreciation & Amortization | 2.38M | 2.38M | 2.38M | 2.99M | 2.99M |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 1.28B | 1.24B | 1.16B | 1.07B | 1.00B |
| Operating Income | 181.56M | 162.99M | 135.61M | 121.19M | 101.95M |
| Income Before Tax | 126.23M | 94.64M | 67.99M | 50.55M | 33.79M |
| Income Tax Expenses | 34.14M | 26.82M | 19.73M | 18.76M | 14.47M |
| Earnings from Continuing Operations | 92.09 | 67.82 | 48.26 | 31.79 | 19.32 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 92.09M | 67.82M | 48.26M | 31.79M | 19.32M |
| EBIT | 181.56M | 162.99M | 135.61M | 121.19M | 101.95M |
| EBITDA | 230.89M | 211.00M | 179.79M | 162.15M | 139.49M |
| EPS Basic | 2.27 | 1.67 | 1.19 | 0.78 | 0.48 |
| Normalized Basic EPS | 2.14 | 1.75 | 1.47 | 1.21 | 0.87 |
| EPS Diluted | 2.26 | 1.66 | 1.18 | 0.78 | 0.47 |
| Normalized Diluted EPS | 2.13 | 1.74 | 1.46 | 1.21 | 0.86 |
| Average Basic Shares Outstanding | 162.09M | 162.06M | 162.03M | 162.03M | 162.01M |
| Average Diluted Shares Outstanding | 163.24M | 163.00M | 162.71M | 162.61M | 162.42M |
| Dividend Per Share | 0.48 | 0.48 | 0.48 | 0.48 | 0.48 |
| Payout Ratio | 21.13% | 28.69% | 40.30% | 61.17% | 100.64% |